Pop Quiz #69
The correct answer is C. Renal Artery Stenosis. This kodachrome is of a patient with neurofibromatosis. Hypertension in NF is typically caused by renal artery stenosis or less likely, a pheochromocytoma. ed by renal artery stenosis or less likely, a pheochromocytoma. Autonomic Dysregulation, Optic Glioma, and medications are less likely causes of hypertension in NF.   References: …
Controversies in Photoprotection
Controversies in PhotoprotectionNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference interviewed Dr. Adam Friedman, Professor, Interim Chair of Dermatology, and Residency Program Director at George Washington University, on some of the common misconceptions and controversies surrounding photoprotection. With ample evidence today that shows that sunscreen both reduces the incidence of me …
Controversies in Photoprotection
COVID-19: The Resident and Program Director Perspective
THE IMPACT OF COVID-19 ON DERMATOLOGY RESIDENCYEPI Health has graciously supported the COVID-19 News and Resource Center. On April 22nd, 2020, the Journal of Drugs in Dermatology, Derm In-Review, and the George Washington School of Medicine and Health Sciences hosted a live webinar to answer resident concerns during the global coronavirus pandemic. The webinar was moderated by Dr. Adam Friedman, Professor and Interim Chair of Dermatology a …
THE IMPACT OF COVID-19 ON DERMATOLOGY RESIDENCY
Hydroxychloroquine, Pentoxifylline, and Colchicine: Off-Label is ON in Dermatology
Hydroxychloroquine, Pentoxifylline, and Colchicine: Off-Label is ON in Dermatology!So many diseases, so few FDA approved indications. Between the mind-numbing time and cost from bench to bottle, it is no surprise that dermatologists, as masters of the integument are the off-label bandits, marrying their wealth of knowledge on the pathophysiology of skin diseases to the mechanisms by which medications work to create an evidenced-based armament of therapies for both common and rar …
Hydroxychloroquine, Pentoxifylline, and Colchicine: Off-Label is ON in Dermatology!
Psoriasis in Skin of Color: Pearls from the Expert
Psoriasis in Skin of ColorAs a first-year dermatology resident, I really enjoyed Dr. Andrew Alexis’ lecture on Psoriasis: Distinct Clinical Features and Treatment Options for Psoriasis Patients of Color at the Skin of Color Update. His lecture largely focused on the fundamentals of dermatology. He emphasized the importance of looking at color and distribution of the clinical presentation and recognizing common mimickers …
Psoriasis in Skin of Color